![Joseph Gilliam](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Gilliam
Präsident bei GLAUKOS CORPORATION
Vermögen: 10 Mio $ am 30.11.2025
Profil
Joseph E.
Gilliam currently works at Caris Life Sciences, Inc., as Independent Director from 2021, Avedro, Inc., as Director from 2019, and Glaukos Corp., as President & Chief Operating Officer from 2022.
Mr. Gilliam also formerly worked at JPMorgan Chase & Co., as Managing Director-Healthcare Investment Banking from 2013 to 2017.
Mr. Gilliam received his undergraduate degree in 1998 from Kelley School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GLAUKOS CORP 0,16 % | 18.11.2025 | 92.366 ( 0,16 % ) | 10 Mio $ | 30.11.2025 |
| 18.06.2025 | 0 ( -.--% ) | - $ | 30.11.2025 |
Aktuelle Nachrichten zu Joseph Gilliam
Aktive Positionen von Joseph Gilliam
| Unternehmen | Position | Beginn |
|---|---|---|
| GLAUKOS CORPORATION | Präsident | 01.04.2022 |
| AVEDRO, INC. | Direktor/Vorstandsmitglied | 21.11.2019 |
| CARIS LIFE SCIENCES, INC. | Direktor/Vorstandsmitglied | 01.04.2021 |
Ehemalige bekannte Positionen von Joseph Gilliam
| Unternehmen | Position | Ende |
|---|---|---|
| JPMORGAN CHASE & CO. | Corporate Officer/Principal | 01.05.2017 |
Ausbildung von Joseph Gilliam
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
JPMorgan Chase & Co.
 JPMorgan Chase & Co. Major BanksFinance Provides banking, asset management, investment banking, credit card and mortgage services | Finance |
Avedro, Inc.
 Avedro, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic medical devices and pharmaceutical products | Health Technology |
Glaukos Corp.
 Glaukos Corp. Medical SpecialtiesHealth Technology Operates as an ophthalmic medical device company | Health Technology |
Caris Life Sciences, LLC
 Caris Life Sciences, LLC BiotechnologyHealth Technology Operates as an AI-powered biotech company that provides molecular profiling services to develop oncology pharmaceuticals with proprietary platform | Health Technology |
Kelley School of Business
 Kelley School of Business Functions as a College/University |
